Antiviral chemotherapy in 2009: quo vadis?

被引：1
作者：
De Clercq, Erik [1 ]
机构：
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
来源：
FUTURE VIROLOGY | 2009年 / 4卷 / 04期
关键词：
PREEXPOSURE PROPHYLAXIS; DISCOVERY; HIV; INFECTION; DRUGS; TRANSMISSION; RALTEGRAVIR; RETROVIRUS; TENOFOVIR; INFLUENZA;
D O I：
10.2217/FVL.09.23
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：313 / 315
页数：3
相关论文
共 23 条
[1]   Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings [J].
Abbas, Ume L. ;
Anderson, Roy M. ;
Mellors, John W. .
PLOS ONE, 2007, 2 (09)
[2]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[3]   Antiviral drugs for cytomegalovirus diseases [J].
Biron, Karen K. .
ANTIVIRAL RESEARCH, 2006, 71 (2-3) :154-163
[4]  
Biswas Subhajit, 2008, Antiviral Chemistry & Chemotherapy, V19, P1
[5]   Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection [J].
Cooper, David A. ;
Steigbigel, Roy T. ;
Gatell, Jose M. ;
Rockstroh, Jurgen K. ;
Katlama, Christine ;
Yeni, Patrick ;
Lazzarin, Adriano ;
Clotet, Bonaventura ;
Kumar, Princy N. ;
Eron, Joseph E. ;
Schechter, Mauro ;
Markowitz, Martin ;
Loutfy, Mona R. ;
Lennox, Jeffrey L. ;
Zhao, Jing ;
Chen, Joshua ;
Ryan, Desmond M. ;
Rhodes, Rand R. ;
Killar, John A. ;
Gilde, Lucinda R. ;
Strohmaier, Kim M. ;
Meibohm, Anne R. ;
Miller, Michael D. ;
Hazuda, Daria J. ;
Nessly, Michael L. ;
DiNubile, Mark J. ;
Isaacs, Robin D. ;
Teppler, Hedy ;
Nguyen, Bach-Yen .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :355-365
[6]   The design of drugs for HIV and HCV [J].
De Clercq, Erik .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (12) :1001-1018
[7]   From adefovir to Atripla(TM) via tenofovir, Viread(TM) and Truvada(TM) [J].
De Clercq, Erik .
FUTURE VIROLOGY, 2006, 1 (06) :709-715
[8]   Antiviral agents active against influenza A viruses [J].
De Clercq, Erik .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) :1015-1025
[9]   Antiviral Drug Discovery: Ten More Compounds, and Ten More Stories (Part B) [J].
De Clercq, Erik .
MEDICINAL RESEARCH REVIEWS, 2009, 29 (04) :571-610
[10]   Another Ten Stories in Antiviral Drug Discovery (Part C): "Old" and "New" Antivirals, Strategies, and Perspectives [J].
De Clercq, Erik .
MEDICINAL RESEARCH REVIEWS, 2009, 29 (04) :611-645
123